Design and synthesis of a tetrahydropyran-based inhibitor of mammalian ribonucleotide reductase

作者: Amos B. Smith , Setsuya Sasho , Bari A. Barwis , Paul Sprengeler , Joseph Barbosa

DOI: 10.1016/S0960-894X(98)00575-7

关键词:

摘要: A tetrahydropyran-based inhibitor (2) of mammalian ribonucleotide reductase (mRR) has been designed and synthesized based on the heptapeptide, N-AcFTLDADF (1), corresponding to C-terminus R2 subunit mRR. Inhibition studies revealed that 2 is indeed a competent inhibitor, albeit less potent than 1.

参考文章(22)
Joseph G. Cory, Ann H. Cory, Germana Rappa, Aurelio Lorico, Liu Mao-Chin, Lin Tai-Shun, Alan C. Sartorelli, Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones. Biochemical Pharmacology. ,vol. 48, pp. 335- 344 ,(1994) , 10.1016/0006-2952(94)90105-8
Bert Fraser-Reid, Robert David Dawe, Deen Bhandu Tulshian, Stereoselective routes to some unsaturated α- and β-C-glycopyranosides Canadian Journal of Chemistry. ,vol. 57, pp. 1746- 1749 ,(1979) , 10.1139/V79-279
E. A. Cohen, P. Gaudreau, P. Brazeau, Y. Langelier, Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature. ,vol. 321, pp. 441- 443 ,(1986) , 10.1038/321441A0
C. H. Baker, J. Banzon, J. M. Bollinger, J. Stubbe, V. Samano, M. J. Robins, B. Lippert, E. Jarvi, R. Resvick, 2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase. Journal of Medicinal Chemistry. ,vol. 34, pp. 1879- 1884 ,(1991) , 10.1021/JM00110A019
Ralph Hirschmann, John Hynes,, Maria A. Cichy-Knight, Rachel D. van Rijn, Paul A. Sprengeler, P. Grant Spoors, William C. Shakespeare, Sherrie Pietranico-Cole, Joseph Barbosa, Josephine Liu, Wenqing Yao, Susan Rohrer, Amos B. Smith, Modulation of receptor and receptor subtype affinities using diastereomeric and enantiomeric monosaccharide scaffolds as a means to structural and biological diversity. A new route to ether synthesis. Journal of Medicinal Chemistry. ,vol. 41, pp. 1382- 1391 ,(1998) , 10.1021/JM9800346
Pierrette Gaudreau, Paul Brazeau, Manon Richer, Jean Cormier, Daniel Langlois, Yves Langelier, Structure-function studies of peptides inhibiting the ribonucleotide reductase activity of herpes simplex virus type I. Journal of Medicinal Chemistry. ,vol. 35, pp. 346- 350 ,(1992) , 10.1021/JM00080A021
Alison Fisher, Paul B. Laub, Barry S. Cooperman, NMR structure of an inhibitory R2 C-terminal peptide bound to mouse ribonucleotide reductase R1 subunit. Nature Structural & Molecular Biology. ,vol. 2, pp. 951- 955 ,(1995) , 10.1038/NSB1195-951
Bernadette M. Dutia, Margaret C. Frame, John H. Subak-Sharpe, William N. Clark, Howard S. Marsden, Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides Nature. ,vol. 321, pp. 439- 441 ,(1986) , 10.1038/321439A0
Alison Fisher, Fu De Yang, Harvey Rubin, Barry S. Cooperman, R2 C-terminal peptide inhibition of mammalian and yeast ribonucleotide reductase. Journal of Medicinal Chemistry. ,vol. 36, pp. 3859- 3862 ,(1993) , 10.1021/JM00076A015